-
Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial.
Tomko RL, Baker NL, McClure EA, Sonne SC, McRae-Clark AL, Sherman BJ, Gray KM. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug and Alcohol Dependence 2018;182:1-7.
-
Psychometrics of the self-report Concise Associated Symptoms Tracking Scale (CAST-SR): Results from the STRIDE (CTN-0037) study.
Trombello JM, Killian MO, Liao A, Sanchez K, Greer TL, Walker NR, Grannemann B, Rethorst CD, Carmody T, Trivedi MH. Psychometrics of the self-report Concise Associated Symptoms Tracking Scale (CAST-SR): Results from the STRIDE (CTN-0037) study. Journal of Clinical Psychiatry 2018;79(1):17m11707.
-
Patterns of substance use and arrest histories among hospitalized HIV drug users: A latent class analysis.
Shiu-Yee K, Brincks AM, Feaster DJ, Frimpong JA, Nijhawan A, Mandler RN, Schwartz RP, del Rio C, Metsch LR. Patterns of substance use and arrest histories among hospitalized HIV drug users: A latent class analysis. AIDS and Behavior 2018;22(9):2757-2765.
-
Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes.
Wu LT, Ghitza UE, Zhu H, Spratt S, Swartz MS, Mannelli P. Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes. Drug and Alcohol Dependence 2018;186:86-93.
-
Exploring longitudinal course and treatment-baseline severity interactions in secondary outcomes of smoking cessation treatment in individuals with attention-deficit hyperactivity disorder.
Luo SX, Wall M, Covey LS, Hu M, Scodes JM, Levin FR, Nunes EV, Winhusen TJ. Exploring longitudinal course and treatment-baseline severity interactions in secondary outcomes of smoking cessation treatment in individuals with attention-deficit hyperactivity disorder. American Journal of Drug and Alcohol Abuse 2018;44(6):653-659.
-
Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system.
Campbell CI, Bahorik AL, VanVeldhuisen PC, Weisner C, Rubinstein AL, Ray, GT. Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system. Preventive Medicine 2018;110:31-37.
-
Baseline cigarette smoking status as a predictor of virologic suppression and CD4 cell count during one-year follow-up in substance users with uncontrolled HIV infection.
Winhusen TJ, Feaster DJ, Ruan R, Brown JL, Daar ES, Mandler RN, Metsch LR. Baseline cigarette smoking status as a predictor of virologic suppression and CD4 cell count during one-year follow-up in substance users with uncontrolled HIV infection. AIDS and Behavior 2018;22(6):2026–2032
-
Neurocognitive profiling of adult treatment seekers enrolled in a clinical trial of a web-delivered intervention for substance use disorders.
Aharonovich E, Campbell ANC, Shulman M, Hu M, Kyle T, Winhusen TJ, Nunes EV. Neurocognitive profiling of adult treatment seekers enrolled in a clinical trial of a web-delivered intervention for substance use disorders. Journal of Addiction Medicine 2018;12(2):99-106.
-
Age differences in outcomes among patients in the “STimulant Abuser Groups to Engage in 12-Step” (STAGE-12) intervention.
Garrett SB, Doyle SR, Peavy KM, Wells EA, Owens MD, Shores-Wilson K, DiCenzo J, Donovan DM. Age differences in outcomes among patients in the "STimulant Abuser Groups to Engage in 12-Step" (STAGE-12) intervention. Journal of Substance Abuse Treatment 2018;84:21-29.
-
Temporal relationship of sex risk behaviors and substance use severity among men in substance use treatment.
Newville H, Sorensen JL, Hatch-Maillette MA, Calsyn DA. Temporal relationship of sex risk behaviors and substance use severity among men in substance use treatment. Journal of Sex Research 2018;55:1056-1064.